Open AccessHuman Rights and Global Pharma Converge
Author(s) -
The Hon Michael Kirby AC
Publication year - 2019
Publication title -
qut law review
Language(s) - English
Resource type - Journals
eISSN - 2205-0507
pISSN - 2201-7275
DOI - 10.5204/qutlr.v18i2.766
Subject(s) - intellectual property , human immunodeficiency virus (hiv) , human rights , international law , public health , law , political science , sociology , economic growth , economics , medicine , virology , nursing
In this article, based on the annual public oration of the Australian Centre for Health Law Research at QUT, Michael Kirby explores the interaction between the discovery of life saving and health preserving pharmaceuticals and international intellectual property (IP) law. He explains the investigation of this topic in a number of transnational bodies in which he has worked. He outlines the specific benefits of antiretroviral medicines for treatment of HIV causing AIDS and HCV (Hepatitis C). He explains the advent of the United Nations Sustainable Development Goals in 2015 and his participation in a High Level Panel created by the UN Secretary General to ensure their attainment. The article closes with some suggested further directions in international IP law and health access.